Ezra's Notes Checked November 16, 2026
Investor Holdings

By @ezracrangle

← Seth Klarman, latest 13F

Seth Klarman · Q1 2019

Baupost Group

Portfolio at the end of Q1 2019, from the 13F filed May 15, 2019. See the filing on EDGAR ↗

CompanyWeightValueSharesPriceHeld sinceChange
eBay EBAY · history 9.1% $1.09B 29,286,000 $37.14 Q4 2018 Add 39%
Viasat VSAT · history 8.9% $1.06B 13,732,068 $77.50 Q2 2013 or earlier No change
Fox Corporation FOXA · history 8.4% $1.00B 27,322,720 $36.71 Q1 2019 Buy
Liberty Global LBTYK · history 8.0% $946.4M 39,092,995 $24.21 Q3 2018 Add 31%
Cheniere Energy LNG · history 7.2% $862.6M 12,618,308 $68.36 Q1 2014 Reduce 11%
Qorvo QRVO · history 6.4% $759.6M 10,589,082 $71.73 Q1 2017 Reduce 1%
Allergan AGN · history 5.9% $698.3M 4,769,695 $146.41 Q1 2016 No change
Synchrony SYF · history 3.8% $454.9M 14,260,557 $31.90 Q3 2016 Reduce 2%
PG&E PCG · history 3.7% $436.1M 24,500,000 $17.80 Q1 2018 Add 58%
CBS CBS · history 3.4% $406.0M 8,542,016 $47.53 Q4 2018 Add 235%
Celgene CELG · history 3.2% $377.4M 4,000,000 $94.34 Q1 2019 Buy
McKesson MCK · history 2.8% $329.5M 2,815,011 $117.06 Q3 2017 Add 64%
Tesla TSLA.CV · convertible notes · history 2.8% $328.3M 300,000,000 prn Q1 2018 No change
Pioneer Natural Resources PXD · history 2.6% $304.8M 2,001,814 $152.28 Q3 2017 Reduce 56%
DigitalBridge CLNY · history 2.2% $264.3M 49,687,370 $5.32 Q2 2018 No change
Atara Biotherapeutics ATRA · history 2.1% $253.6M 6,380,519 $39.75 Q4 2014 Add 2%
Antero Resources AR · history 2.1% $252.4M 28,587,791 $8.83 Q3 2014 No change
Takeda Pharmaceutical TAK · history 1.8% $217.3M 10,669,021 $20.37 Q1 2019 Buy
Theravance Biopharma TBPH · history 1.8% $211.0M 9,309,168 $22.67 Q2 2014 No change
Univar Solutions UNVR · history 1.8% $210.5M 9,500,000 $22.16 Q3 2018 No change
Fox Corporation FOX · history 1.7% $203.8M 5,680,307 $35.88 Q1 2019 Buy
Akebia Therapeutics AKBA · history 1.7% $200.4M 24,471,453 $8.19 Q4 2018 No change
Cencora COR · history 1.6% $191.2M 2,404,299 $79.52 Q3 2017 Add 19%
Bristol-Myers Squibb BMY · history 1.6% $190.8M 4,000,000 $47.71 Q1 2019 Buy
Liberty Global LBTYA · history 1.0% $123.5M 4,957,205 $24.92 Q3 2018 No change
Sinclair SBGI · history 0.9% $111.9M 2,908,096 $38.48 Q2 2018 Reduce 3%
Nexstar Media Group NXST · history 0.9% $108.4M 1,000,000 $108.37 Q4 2018 Add 5%
Veritiv VRTV · history 0.8% $93.8M 3,564,439 $26.32 Q3 2014 No change
Translate Bio TBIO · history 0.5% $63.9M 6,491,298 $9.85 Q2 2018 No change
Disney DIS · history 0.4% $44.3M 399,151 $111.03 Q1 2019 Buy
Trilogy Metals TMQ · history 0.3% $32.0M 13,050,758 $2.45 Q2 2013 or earlier No change
Theravance Biopharma TBPH.CV · convertible notes · history 0.2% $29.2M 30,000,000 prn Q4 2016 No change
Gossamer Bio GOSS · history 0.2% $26.1M 1,267,171 $20.61 Q1 2019 Buy
Paratek Pharmaceuticals PRTK · history 0.1% $12.8M 2,394,498 $5.36 Q4 2014 No change
GTY Technology GTYH.WS · warrants · history 0.0% $884K 1,466,666 $0.60 Q4 2018 No change
35 positions100.0%$11.90B

Weight is the position's share of the total value in this 13F, not of the whole fund. Price is the value divided by the number of shares, so it's the price at the end of the quarter, as the firm reported it. Change compares share counts with Q4 2018, adjusted for stock splits.

Sector weighting

Sector weights in this 13F
Media & telecom33.7%
Health care23.5%
Energy11.9%
Consumer discretionary11.9%
Technology6.4%
Financials & real estate6.0%
Utilities3.7%
Industrials2.6%
Materials0.3%

What changed from Q4 2018

← Q4 2018 Q2 2019 →